Literature DB >> 12530663

Function of the transcriptional regulating protein of 132 kDa (TReP-132) on human P450scc gene expression.

Florence Gizard1, Mohamed El-Alfy, Yannick Duguay, Bernard Lavallée, Fredérique DeWitte, Bart Staels, Barbara G Beatty, Dean W Hum.   

Abstract

Cytochrome P450scc catalyzes the important first step in the steroid synthesis pathway; however, it is clear that additional factors regulating the temporal and spacial specific expression of the CYP11A1 gene remain to be identified. To isolate novel transcription factors that regulate this gene, a cis-acting element of the 5'-flanking region from nucleotides -155 to -131 (-155/-131) was used to screen a human placental lambda gt11 cDNA expression library, and an interacting clone was isolated. The open reading frame of the cDNA encodes several domains that are characteristic of transcription factors including an acidic region, a region rich in prolines and three zinc-finger motifs. Expression of the cDNA by in vitro transcription/translation and by transient transfection in HeLa cells yielded a protein of 132 kDa, which concurs with the predicted size. Transfection of the cDNA in placental JEG-3 and adrenal NCI-H295 cells, stimulate expression of a reporter construct controlled by the P450scc gene 5'-flanking region from nucleotides -1676 to +49. This transcriptional regulating protein of 132kDa (TReP-132) when expressed in HeLa cells was demonstrated to interact with the -155/-131 region in bandshift analysis, and tandem copies of this region was shown to confer activation of the heterologous HSV thymidine kinase minimal promoter. Coexpression of CBP/p300 with TReP-132 further increased promoter activity, and the proteins were demonstrated to interact physically. RNA analysis demonstrated the highest levels of expression in the adrenal cortex and testis; and transcript expression is also found in the steroidogenic JEG-3, NCI-H295, and MCF-7 cell lines, but not in non-steroidogenic HepG2 and HK293 cells. Subsequently it has been shown that TReP-132 interacts with steroidogenic factor-1 (SF-1) through specific domains; and along with the interaction with CBP/p300 these factors are postulated to form a complex to regulate expression of the P450scc gene.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12530663     DOI: 10.1081/erc-120016841

Source DB:  PubMed          Journal:  Endocr Res        ISSN: 0743-5800            Impact factor:   1.720


  4 in total

1.  TReP-132 is a novel progesterone receptor coactivator required for the inhibition of breast cancer cell growth and enhancement of differentiation by progesterone.

Authors:  Florence Gizard; Romain Robillard; Barbara Gross; Olivier Barbier; Françoise Révillion; Jean-Philippe Peyrat; Gérard Torpier; Dean W Hum; Bart Staels
Journal:  Mol Cell Biol       Date:  2006-10       Impact factor: 4.272

2.  TReP-132 controls cell proliferation by regulating the expression of the cyclin-dependent kinase inhibitors p21WAF1/Cip1 and p27Kip1.

Authors:  Florence Gizard; Romain Robillard; Olivier Barbier; Brigitte Quatannens; Anne Faucompré; Françoise Révillion; Jean-Philippe Peyrat; Bart Staels; Dean W Hum
Journal:  Mol Cell Biol       Date:  2005-06       Impact factor: 4.272

3.  Novel candidate genes for ECT response prediction-a pilot study analyzing the DNA methylome of depressed patients receiving electroconvulsive therapy.

Authors:  Nicole Moschny; Tristan Zindler; Kirsten Jahn; Marie Dorda; Colin F Davenport; Lutz Wiehlmann; Hannah B Maier; Franziska Eberle; Stefan Bleich; Alexandra Neyazi; Helge Frieling
Journal:  Clin Epigenetics       Date:  2020-07-29       Impact factor: 6.551

4.  SF-1 a key player in the development and differentiation of steroidogenic tissues.

Authors:  Pierre Val; Anne-Marie Lefrançois-Martinez; Georges Veyssière; Antoine Martinez
Journal:  Nucl Recept       Date:  2003-09-18
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.